L&C BIO Co.,LTD (290650.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩23,800 (-4.42%) as of
Key statistics
- Market cap
- 1.45T
- Forward P/E
- 28.22
- Dividend yield
- 0.10%
- 52-week range
- 20,380.56 – 60,440.56
- Beta
- 1.51
- Revenue (TTM)
- 116.3B
- Profit margin
- -128.47%
- Analyst target
- ₩45,250
- Volume
- 371.27k
About L&C BIO Co.,LTD
L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Seongnam-si, South Korea
- Employees
- 181
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.